The authors are retracting their accepted manuscript “MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway” at the request of the corresponding author and Hunan Provincial Tumor Hospital, in conjunction with the policies of their Institutional Review Board (IRB), as their study had not been granted at Hunan Provincial Tumor Hospital. The gene discussed is AKT1; the disease is hepatocellular carcinoma.